A clinical trial to evaluate the safety and tolerability of stem cells from human exfoliated deciduous teeth in children with cerebral palsy.

Sato Yoshiaki0 个研究点目标入组 3 人开始时间: 2023年6月22日最近更新: 2023年11月20日

适应症

试验速览

暂无简介。

•1) Patients aged 6 to 11 who were diagnosed with cerebral palsy at a medical institution
•2) Patients diagnosed with neonatal hypoxic-ischemic encephalopathy (HIE) at a medical institution
•3) Patients with GMFCS level II or III
•4) Patients with deciduous teeth that are slightly mobile or who have previously lost deciduous teeth
•5) Patients with deciduous central or lateral incisors without cavity of C2 or higher
•6) Patients who obtained written consent from the legal representative of the patient

•1) Patients participating in other clinical trials (excluding observational studies)
•2) Patients with confirmed or suspected severe congenital abnormalities or chromosomal abnormalities
•3) Patients who have been judged by the attending physician to be unable to extract a tooth with local anesthesia
•4) Patients undergoing or scheduled to undergo tendonectomy within one year
•5) Patients who received botulinum toxin injection within 6 months
•6) Patients with active or suspected serious infections
•7) Patients who are positive for HBs antigen, HCV antibody, HIV antibody, HTLV-1 antibody, or serologic test for syphilis
•8) Patients diagnosed with diabetes
•9) Patients with a history of severe hypersensitivity or anaphylactic reaction
•10) Patients with other serious underlying diseases
•11) Patients with liver or renal dysfunction
•12) Patients who are judged to be inappropriate by the attending physician

发起方

Sato Yoshiaki